Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Smoking Cessation 2Vaping 1Uterine Cervical Dysplasia 1Tobacco Use Disorder 1Tobacco Smoking 1Substance-Related Disorders 1Lung Neoplasms 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nicotine Replacement Therapy × 90 days × Clear all
NCT05144542 2026-04-15

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
140 enrolled
Thoracic

Lung Neoplasms

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

University of Oklahoma

Phase NA Completed
31 enrolled
Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT05515354 2026-03-19

MC-NRT

Centre for Addiction and Mental Health

Phase 4 Recruiting
1,200 enrolled

Tobacco Smoking, Tobacco Use Disorder, Smoking Cessation, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡